Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ii/Iii, Randomized, Double Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America

NCT00084227 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00084227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00084227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ii/Iii, Randomized, Double Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America
Lead sponsor
Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2004
Completion date
July 31, 2005
Enrollment
244 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, falciparum